Results 81 to 90 of about 62,487 (100)
Some of the next articles are maybe not open access.

On The Efficacy of Cobalt Boride Coating on NMC-811 Cathode Under Vinylene Carbonate Additive, High Temperature and Air Shelving Conditions

Journal of the Electrochemical Society, 2023
Cobalt boride (CoB) is a novel coating material for high-voltage cathodes, which has demonstrated excellent protective capabilities for the NMC-811 cathode in the LiPF6-EC-EMC electrolyte.
Y. Jing, Y. Shao, H. Xin
semanticscholar   +1 more source

Pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study.

Journal of Clinical Oncology, 2021
4013 Background: Trastuzumab (tras) plus chemotherapy (chemo) is standard-of-care (SOC) 1L therapy for HER2+ metastatic G/GEJ cancer. In two phase 2 studies, tras, chemo, and pembrolizumab (pembro) in combination showed promising efficacy and manageable ...
Y. Janjigian   +18 more
semanticscholar   +1 more source

Bipolar redox electrolyte-synergistically mediated NiCoMn-811 high-Ni ternary perovskite fluorides for advanced supercapacitors in both alkaline and neutral media

, 2021
Perovskite fluorides (ABF3) as novel electrode materials have drawn particular attention for supercapacitors (SCs). However, the key issues to enhance energy storage capability, clarify charge storage mechanisms, employ different electrolytes media, and ...
Wei Shi   +8 more
semanticscholar   +1 more source

Efficient Pyrazolo[5,4-f]quinoxaline Functionalized Os(II) based Emitter with Electroluminescence Peak Maximum at 811 nm.

Chemistry, 2021
Upon fusing the pyrazinyl pyrazole entity in giving pyrazolo[3,4- f ]quinoxaline chelate, the corresponding Os(II) based NIR emitter exhibited "invisible" and efficient electroluminescence with peak max.
Ze‐Lin Zhu   +9 more
semanticscholar   +1 more source

Editors' Choice—Capacity Fading Mechanisms of NCM-811 Cathodes in Lithium-Ion Batteries Studied by X-ray Diffraction and Other Diagnostics

Journal of the Electrochemical Society, 2019
Ni-rich layered oxides, like NCM-811, are promising lithium-ion battery cathode materials for applications such as electric vehicles.
F. Friedrich   +7 more
semanticscholar   +1 more source

Li-Nb-O coating/substitution enhances the electrochemical performance of LiNi0.8Mn0.1Co0.1O2 (NMC 811) Cathode.

ACS Applied Materials and Interfaces, 2019
High-nickel layered oxides, such as NMC 811, are very attractive high energy density cathode materials. However, the high nickel content creates a number of challenges, including high surface reactivity and structural instability. Through a wet chemistry
F. Xin   +6 more
semanticscholar   +1 more source

Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial results.

Journal of Clinical Oncology
286 Background: In the phase 3 KEYNOTE-811 study (NCT03615326), first-line (1L) pembro with tras + chemo (pembro arm) yielded superior PFS and improved ORR with durable responses versus placebo (pbo) with tras + chemo (pbo arm) in pts with HER2 ...
Y. Janjigian   +14 more
semanticscholar   +1 more source

Cactus pear (Opuntia ficus-indica) juice fermented with autochthonous Lactobacillus plantarum S-811.

Food & Function, 2019
The present study aimed at investigating the lactic fermentation of cactus pear (Opuntia ficus-indica) fruit juice with the autochthonous and potentially probiotic strain Lactobacillus plantarum S-811. L.
Hernán E. Verón   +7 more
semanticscholar   +1 more source

Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients

British Journal of Ophthalmology, 2018
Aims To determine the demographic and morphological characteristics of patients with central serous chorioretinopathy (CSC) and describe risk factors for CSC.
M. Ersoz   +4 more
semanticscholar   +1 more source

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

The Lancet, 2023
Y. Janjigian   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy